Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliKuajiri
Wadhamini
Fudan University

Maneno muhimu

Kikemikali

The purpose of the study is to observe the curative effect and safety of laparoscopic versus open liver resection for hepatocellular carcinoma.

Maelezo

Liver resection is the most important treatment of hepatocellular carcinoma (HCC). Open hepatectomy was regarded as a giant surgery because of its big incision, influence of the liver function, and long hospital stay. Laparoscopic hepatectomy was widely used since it was reported by Reich in 1991. With the constant innovation of laparoscopic technique and equipment, there is no penalty area in laparoscopic hepatectomy. The Louisville consensus proposed that the best indication for laparoscopic hepatectomy was the tumor diameter < 5cm, located in segment II-VI.

Previous studies shows that compared with the open surgery, laparoscopic hepatectomy has the advantages of shorter operation time, less bleeding, shorter hospitalization time. The mortality, mobility, the overall survival and the disease-free survival was same in these two groups.

So far, however, the curative effect and safety research of laparoscopic versus open liver resection for HCC is limited to retrospective study and case-control study. A prospective, randomized, controlled study is urgently needed.

This study was proceeded to observe the curative effect and safety of laparoscopic versus open liver resection for HCC.

Tarehe

Imethibitishwa Mwisho: 01/31/2019
Iliyowasilishwa Kwanza: 08/04/2015
Uandikishaji uliokadiriwa Uliwasilishwa: 08/13/2015
Iliyotumwa Kwanza: 08/17/2015
Sasisho la Mwisho Liliwasilishwa: 02/10/2019
Sasisho la Mwisho Lilichapishwa: 02/11/2019
Tarehe halisi ya kuanza kwa masomo: 07/31/2015
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 05/31/2019
Tarehe ya Kukamilisha Utafiti: 11/30/2020

Hali au ugonjwa

Hepatocellular Carcinoma

Uingiliaji / matibabu

Procedure: laparoscopic hepatectomy

Procedure: Open hepatectomy

Awamu

-

Vikundi vya Arm

MkonoUingiliaji / matibabu
Experimental: laparoscopic hepatectomy
The HCC patients who meet the Louisville consensus will be underwent the liver resection by laparoscopic surgery
Procedure: laparoscopic hepatectomy
The HCC patients who meet the Louisville consensus will underwent liver resection by laparoscopy
Experimental: Open hepatectomy
The HCC patients who meet the Louisville consensus will be underwent the liver resection by open surgery
Procedure: Open hepatectomy
The HCC patients who meet the Louisville consensus will underwent liver resection by open surgery

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 18 Years Kwa 18 Years
Jinsia Inastahiki KujifunzaAll
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

1. Diagnosis was HCC

2. The tumor was located in segment: II, III, IVb, V, VI

3. The tumor diameter < 5cm

4. Without thrombosis in the portal vein, hepatic vein or bile duct

5. Without intrahepatic and systemic metastasis

6. The Child-pugh score was A-B7

7. The ASA(American Society of Anesthesiologists) score was I-III

8. The patient age was between 18-75

9. Sign the informed consent, and can fully understand the research content

Exclusion Criteria:

1. Have surgery contraindications

2. Pregnant or lactating women

3. The Child-pugh score was B8-C

4. The ASA(American Society of Anesthesiologists) score was IV-V

5. With other malignant tumor

6. With mental illness

7. Participated in other clinical trials in the last three months

8. Underwent other treatments(chemotherapy or radiotherapy) before operation

Matokeo

Hatua za Matokeo ya Msingi

1. Overall survival [5 years]

Hatua za Matokeo ya Sekondari

1. Disease free survival [5 years]

2. The duration of the operation [1 day]

3. The volume of blood loss during operation [1 day]

4. The volume of blood transfusion during operation [1 day]

5. Hospitalization days [7 days]

6. The total costs in hospital [7 days]

7. Total bilirubin measured after operation [7 days]

8. Alanine transaminase measured after operation [7 days]

9. Albumine measured after operation [7 days]

10. The volume of the drainage after operation [7 days]

11. The volume of pleural effusion after operation [7 days]

12. The volume of subphrenic collection after operation [7 days]

13. Change From Baseline in Pain on the 11 point Short Pain Scale (SPS-11) after operation [7 days]

14. The postoperative ECOG score [7 days]

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge